Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Amgen | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Amgen

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Amgen

1Q Revenues: $3.7 billion (+15%)

1Q Earnings: $1.1 billion (+10%)

Comments: Aranesp sales grew 14% to $1 billion; Enbrel sales (Amgen only) rose 11% to $730 million, Neulasta sales were up 17% to $714 million, while Epogen and Neupogen grew modestly, between 3 and 4% to $625 million and $299 million respectively. New product Vectibix posted $51 million it its first 1Q. Sensipar sales were up 72% to $105 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters